Gilead Sciences CapEx increased by 39.5% to $205.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.5%, from $147.00M to $205.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -0.7% CAGR.
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
cf_capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $119.00M | $139.00M | $156.00M | $247.00M | $143.00M | $157.00M | $181.00M | $109.00M | $139.00M | $122.00M | $215.00M | $105.00M | $130.00M | $141.00M | $147.00M | $104.00M | $107.00M | $147.00M | $205.00M |
| QoQ Change | — | +16.8% | +12.2% | +58.3% | -42.1% | +9.8% | +15.3% | -39.8% | +27.5% | -12.2% | +76.2% | -51.2% | +23.8% | +8.5% | +4.3% | -29.3% | +2.9% | +37.4% | +39.5% |
| YoY Change | — | — | — | — | +20.2% | +12.9% | +16.0% | -55.9% | -2.8% | -22.3% | +18.8% | -3.7% | -6.5% | +15.6% | -31.6% | -1.0% | -17.7% | +4.3% | +39.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.